Birchmere Ventures boasts over $115 million in management and a track record of thriving investments in fledgling technology and life sciences companies. Their primary focus is on pre-revenue startups in their early stages, especially those where they have prior investing or operational expertise. They prioritize leading syndicated deals with institutional investors and limit the number of board seats held by each partner.
76
Total Investments
43
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Mobile
Funding Stage
Seed +2
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Birchmere Ventures
Recent Investments (76)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Sep 2023 | |
| Seed Round | •••••• | Mar 2022 | |
| Series C | •••••• | Jun 2021 | |
| Series B | •••••• | Mar 2021 | |
| Series B | •••••• | Dec 2020 | |
|
|
Seed Round | •••••• | Aug 2020 |
|
|
Series A | •••••• | Mar 2020 |
|
|
Venture Round | •••••• | May 2019 |
|
|
Venture Round | •••••• | Feb 2019 |
|
|
Seed Round | •••••• | Oct 2018 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.